2021
DOI: 10.3390/ijms22116088
|View full text |Cite
|
Sign up to set email alerts
|

Gut Serpinome: Emerging Evidence in IBD

Abstract: Inflammatory bowel diseases (IBD) are incurable disorders whose prevalence and global socioeconomic impact are increasing. While the role of host genetics and immunity is well documented, that of gut microbiota dysbiosis is increasingly being studied. However, the molecular basis of the dialogue between the gut microbiota and the host remains poorly understood. Increased activity of serine proteases is demonstrated in IBD patients and may contribute to the onset and the maintenance of the disease. The intestin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 175 publications
0
8
0
Order By: Relevance
“…Several human serpins have been shown to regulate serine proteases associated with processes such as inflammation and immune responses[ 48 ]. And increased activity of serine proteases is demonstrated in IBD patients and may contribute to the onset and the maintenance of the disease[ 49 ]. This appears to be a novel finding that will require additional research.…”
Section: Discussionmentioning
confidence: 99%
“…Several human serpins have been shown to regulate serine proteases associated with processes such as inflammation and immune responses[ 48 ]. And increased activity of serine proteases is demonstrated in IBD patients and may contribute to the onset and the maintenance of the disease[ 49 ]. This appears to be a novel finding that will require additional research.…”
Section: Discussionmentioning
confidence: 99%
“…Heparin and HS enhance this tissue-protective effect; α1-protease inhibitor and members of the superfamily not only have tissue-protective roles in lung tissues but are also potent protective agents in the gut [ 143 , 146 ], and their interactions with heparin and HS further improve their protease inhibitory properties. A group of novel protease inhibitors, the siropins, are also supplied by the gut microbiome and these have tissue-protective properties [ 145 , 147 ]. A serpin from the gut bacterium Bifidobacterium longum inhibits elastase-like serine proteases [ 148 ] in a similar manner to PPS.…”
Section: Pps and The Gutmentioning
confidence: 99%
“…Furthermore, microbial subtilisin has been shown to promote platelet aggregation in vitro [76]; this is of interest as thrombosis and inflammation are also connected in IBD [77]. The role of antisubtilisin inhibitors may thus have some therapeutic potential in this respect [78]. Antimicrobial effects of PIs have been studied to some extent, also regarding some gut health-related species [79].…”
Section: Impact On Gut Microbiota Population and Metabolic Dynamicsmentioning
confidence: 99%